Results 381 to 390 of about 1,451,429 (415)

Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study.

Journal of Clinical Oncology, 2017
Purpose To establish the safety profile and antitumor activity of the anti-programmed death 1 receptor monoclonal antibody, pembrolizumab, in patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) that expressed programmed death-ligand 1
Chiun Hsu, Se-Hoon Lee, S. Ejadi, C. Even, R. Cohen, C. le Tourneau, J. Mehnert, A. Algazi, E. V. van Brummelen, S. Saraf, P. Thanigaimani, Jonathan D. Cheng, A. Hansen   +12 more
semanticscholar   +1 more source

Immunotherapeutic approaches in nasopharyngeal carcinoma

Expert Opinion on Biological Therapy, 2019
Introduction: Nasopharyngeal carcinoma (NPC) is endemic in Southern China and Southeast Asia. Epstein-Barr virus (EBV) represents a unique etiological culprit in the poorly differentiated nonkeratinizing and undifferentiated subtypes.
J. Chow, R. Ngan, K. Cheung, W. Cho
semanticscholar   +1 more source

Nasopharyngeal carcinoma: A review

Seminars in Diagnostic Pathology, 2015
Nasopharyngeal carcinoma is an umbrella term for a group of malignant epithelial tumors with different etiopathogenesis and a broad range of histopathological appearances. Some types have a dramatically skewed geographical and ethnic distribution and shows virtually 100% association with Epstein Barr virus.
openaire   +3 more sources

Immunogenetics of nasopharyngeal carcinoma

Annales de biologie clinique, 2014
Nasopharyngeal carcinoma (NPC) is a complex multifactorial disorder involving both genetic and environmental factors. Genetic predisposition linked to the immune system has been associated with various tumors. This involves genetic diversity of the genes encoding the molecules of the immune response such as inflammation and anti-tumor surveillance.
Arij Ben Chaaben, Hayet Douik, Ryad Tamouza, Rajagopal Krishnamoorthy, Fethi Guemira, Dominique Charron, Hajer Abaza, Latifa Harzallah   +7 more
openaire   +3 more sources

Advances in nasopharyngeal carcinoma

Current Opinion in Oncology, 2008
Nasopharyngeal carcinoma prognosis is related to its potential locoregional invasion and metastatic spread. Among prognostic factors, initial tumor-node-metastasis stage is the main one, besides other biological parameters. Worldwide development of positron emission tomography imaging is changing modalities of staging.
openaire   +3 more sources

Nasopharyngeal Carcinoma

, 1966
Pelayo Vilar
semanticscholar   +1 more source

Chemotherapy and chemo-resistance in nasopharyngeal carcinoma.

European journal of medicinal chemistry, 2020
Shuzhen Guan, Jin-rui Wei, Lingkun Huang, Lichuan Wu   +3 more
semanticscholar   +1 more source

Nasopharyngeal Carcinoma

1976
G. de-Thé, J. H. C. Ho, C. S. Muir
openaire   +1 more source

Nasopharyngeal carcinoma

The Lancet, 1997
E E, Vokes, D N, Liebowitz, R R, Weichselbaum   +2 more
openaire   +2 more sources

Nasopharyngeal carcinoma

Current Opinion in Oncology, 1990
openaire   +2 more sources